Correlations between dietary choline and betaine intakes (mg/kg/day) with body composition¹.

<p>Correlations between dietary choline and betaine intakes (mg/kg/day) with body composition<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0155403#t002fn001" target="_blank">¹</a>.</p

Comparison of body composition and dietary choline, betaine intakes in different obesity status defined by BMI ¹.

<p>Comparison of body composition and dietary choline, betaine intakes in different obesity status defined by BMI <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0155403#t003fn001" target="_blank">¹</a>.</p

Comparison of obesity indexes according to dietary choline (mg/kg/day) intake¹.

<p>Comparison of obesity indexes according to dietary choline (mg/kg/day) intake<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0155403#t005fn001" target="_blank">¹</a>.</p

Obesity indexes and dietary choline, betaine intakes by gender ¹.

<p>Obesity indexes and dietary choline, betaine intakes by gender <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0155403#t001fn001" target="_blank">¹</a>.</p

Composition of body composition and dietary choline, betaine intakes in different obesity status defined by BF%¹.

<p>Composition of body composition and dietary choline, betaine intakes in different obesity status defined by BF%<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0155403#t004fn001" target="_blank">¹</a>.</p

Multiple Regression for Body Fat (%), Trunk Fat (%), and Waist Circumference (cm) on PYY Concentration^1,3.

1<p>Regression model adjusted for age, gender, smoking, medication use (Menopause was also controlled for in the females).</p>2<p>β = Unstandardized Beta (standard error).</p>3<p>Statistical significance was set to p<0.05.</p

Physical, Biochemical, and Dietary Intake Characteristics According to Magnesium Intake.

1<p>Data presented as mean ± SD. Homeostasis model assessment of insulin resistance (HOMA-IR) and β-cell function (HOMA-β).</p>2<p>Subjects were stratified into a tertile (low, medium and high) based upon magnesium intake (mg/day).</p>3<p>Magnesium intake group differences were assessed with an ANCOVA controlling for caloric intake, physical activity, medication use, menopause and %BF.</p>4<p>Statistical significance for one-way ANCOVA was set to p<0.05 (IBM SPSS Statistics 19).</p

Fasting Serum PYY for men and women in four age groups.

<p>Fasting PYY concentration was 15.2%, 17.1% and 11.8% greater among men than women within the <30 yrs, >30–<40 yrs, and >40–<50 yrs groups respectively (*). Additionally, the ≥50 yrs group of women had a 12.2% higher circulating level of PYY than women in the <30 yrs group (†).</p

Pearson correlation of body composition measurements with circulating PYY^1,2.

1<p>Pearson correlation of body composition measurements with PYY (pg/ml).</p>2<p>Statistical significance was set to p<0.05.</p

Fasting serum PYY among normal-weight, overweight and obese males and females.

<p>Fasting PYY concentration was not significantly different between normal-weight (NW), overweight (OW) or obese (OB) subjects defined either by body mass index (BMI) according to the WHO criteria <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0095235#pone.0095235-WorldHealthOrganization1" target="_blank">[28]</a> or percent body fat (%BF) measured by dual-energy x-ray absorptiometry (DXA) according to the Bray criteria <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0095235#pone.0095235-Bray1" target="_blank">[27]</a>. Fasting PYY concentration was also not significantly different among adiposity groups among men and women separately.</p